Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Canton Biologics logo

Canton Biologics

Recent Finacing

Series C

Recent Raise

$41.1M

Canton Biologics is a molecule biopharmaceutical CDMO providing end-to-end CMC development, high-yield cell line development, complex protein and IgM expression, high-density culture, formulation, analytics, and global manufacturing.

Founded 2016
Guangdong, China
101-250
Private
cantonbio.com

Highlights

Focus Areas

Biotechnology
Manufacturing
Outsourcing

Recent Investors

Guotou Chuangye logo
粤科金融 logo
T
C

Financials

$41.1M

Total Raised

1

Funding round

4

Investors


Team

Upgrade to view the team

See the team members at Canton Biologics.